RE:RE:95 k Your plot theory doesn't make sense as any big pharma could buy TLT for peanuts now if they would to.
And they all buy other biotechs for ten of billions of $$$.
And big pharmas are all in competition against each others as TLT is available to any of them. First come, first serve. Up to the best offer. So no plot conspiracy to kill TLT.
So far, TLT has only demonstrated in one indication. Not many. And NSCLC and GBM are very different than Bladder in terms of procedure. It's not just like a drug-only treatment. The way to activate pdc in GBM is totally different than in NSCLC or bladder.
But PDT/PDC can be superior if it has the right molecule that is not toxic until light activated and that can spare healthy cells. So far, our PDC portfolio is interesting with TLD1433 (Ruvidar), Rutherin and some other Os pdcs. Prof. McFarland also created more potent PDCs that we could potentially inherit.
But the "big" ASK is probably someone that wants to accumulate.
_____________
Tcwtaeugene2 - (5/18/2023 5:22:27 PM)
RE:95 k
Another litle mamouth have decide to install is feet at 0.28 before the one at 0.29. Is it a competition or the same player( i dont have the houses so if someone have it, it could be fun to share)? In a other way, does folks believe FDA is neutral and have only the interest of human healt?? Like in the FAA, seems money talk first so if big pharmas decide to crunch a litle player, then they surely try to influence the FDA. Money always talk in those case.Good luck(bis).